Tacrolimus (graceptor (R)) for GVHD prophylaxis after allogeneic stem cell transplantatio
Not Applicable
- Conditions
- acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia, myelodysplastic syndrome, malignant lymphoma
- Registration Number
- JPRN-UMIN000002441
- Lead Sponsor
- Jikei university school of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have internal organs dysfunction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pharmacokinetics of oral tacrolims
- Secondary Outcome Measures
Name Time Method